RFA that is radiofrequency ablation is a simply invasive process, appropriate for patients with cancer; cardiac disease includes cardiac arrhythmias, atrial flutter and atrial fibrillation and pain management. It has developed into a technique of selection because of its safety, ease of use and high efficacy. Radiofrequency removal is utilized by specialists to demolish dangerous cells, to evacuate or trim obstructive tissues, and stifle nerves. The procedure is helped by embeddings a unique needle through the skin onto the tumor and focused to the particular tissue/nerve with radiofrequency electrical vitality to warm the tumor through a dynamic uncovered anode tip. The warming created incites cell passing as a consequence of irreversible protein denaturation. This innovation has wide applications and is utilized as a part of different restorative fields, for example, heart beat, oncology, cerebral tumors, gynecology, and renal enervation for hypertension, Cardiac arrhythmia and cancer, torment administration, and cosmetology.
How Big is the Radiofrequency Ablation Devices Market?
The Global Radiofrequency Ablation Devices Market US$ 1630 million by 2028, with the demand projected to increment at a CAGR of 12.5%.
The major driving factors of Global Radiofrequency Ablation Devices Market are as follows:
• Increase in the prevalence of cardiac diseases and cancer
• High efficacy and little duration of the process
• Rise in the number of patients suffering from pain
The restraining factors of Global Radiofrequency Ablation Devices Market are as follows:
• High cost of treatment
• Availability of other treatments
• Limited awareness
The Global Radiofequency Ablation Devices Market is segmented on the lines of its type, product, application and regional. Based on type segmentation it covers light /laser ablation, hydrothermal ablation, radiofrequency ablation, microwave ablation, electrical ablation, cryoablation and ultrasound ablation. Under product segmentation it covers disposable equipment, reusable equipment and capital equipment. Disposable equipment is further segmented into radiofrequency ablation single use electrodes, radiofrequency ablation single use probes, radiofrequency ablation needles and radiofrequency ablation cannulas. Reusable equipment is classified into radiofrequency ablation electrodes and radiofrequency ablation probes. Capital equipment contains radiofrequency ablation generator. The Global Radiofrequency Ablation Devices Market’s geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Radiofrequency Ablation Devices Market and related technologies.
2) Analysis of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Radiofrequency Ablation Devices Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for various Global Radiofrequency Ablation Devices Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Stryker Corp., Accuray, St. Jude Medical Inc., Neurotherm Inc., Biosense Webster, Diros Technology Inc., Cosman Medical Inc. and Kimberly-Clark Corporation.Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Radiofrequency Ablation Devices Market has been segmented as below:
By Type Analysis
• Light/Laser Ablation
• Hydrothermal Ablation
• Radiofrequency Ablation
• Microwave Ablation
• Electrical Ablation
• Cryoablation
• Ultrasound Ablation
By Product Analysis
Disposable Equipment
o Radiofrequency ablation single use electrodes
o Radiofrequency ablation single use probes
o Radiofrequency ablation needles
o Radiofrequency ablation cannulas
Reusable Equipment
o Radiofrequency ablation electrodes
o Radiofrequency ablation probes
Capital Equipment
o Radiofrequency ablation generator
By Application Analysis
• Surgical oncology
• Cosmetology
• Hypertension
• Gynecology
• Pain management
• Cardiology and cardiac rhythm management
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Radiofrequency Ablation Devices Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Radiofrequency Ablation Devices Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Interventional Cardiology & Peripheral Vascular Devices Market
Patient Monitoring Devices Equipment’s Systems Market
Attention Deficit Hyperactivity Disorder Therapeutics market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Methodology Steps
2.2 Research Design
2.3 Secondary and Primary Research Methodology
2.3.1 Secondary Research
2.3.1.1 Key Data From Secondary Sources
2.3.2 Primary Research
2.3.2.1 Key Data From Primary Sources
2.3.3 Market Size Estimation Methodology
2.4 Opportunity Indicators
2.4.1 Demand-Side Analysis
2.4.1.1 Incidence and Prevalence of Cancer
2.4.1.2 Rapid Growth of Geriatric Population
2.4.1.3 Significant Number of Clinical Researches in Ablation
2.4.2 Supply-Side Analysis
2.4.2.1 Clinical Trials By Ablation Technology
2.4.2.2 Number of New Product Launches: Ablation Market (2013–2016)
2.5 Market Data Validation and Triangulation
2.6 Assumptions for the Study
3 Executive Summary
3.1 Introduction
3.2 Conclusion
4 Premium Insights
4.1 Global Ablation Technology Market Overview
4.2 Geographical Snapshot of the Global Ablation Technology Market
4.3 Global Ablation Technology Market, By Type and Region
4.4 Global Ablation Technology Market, By Application
4.5 Global Ablation Technology Market Size, By Product (2016 vs 2021)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Emergence of Next-Generation Ablation Products and Technology
5.2.1.2 Rising Incidence of Cancer
5.2.1.3 Growing Prevalence of Cardiovascular Diseases
5.2.1.4 Increasing Number of Ablation Procedures
5.2.1.5 Increasing Number of Hospitals, Surgical, and Ablation Centers
5.2.2 Restraints
5.2.2.1 Reuse and Reprocessing of Devices in Developing Countries
5.2.2.2 Healthcare Cost-Containment Measures
5.2.2.3 Unfavorable Regulatory Scenario
5.2.3 Opportunities
5.2.3.1 Growth Potential Offered By Emerging Markets
5.2.3.2 Rising Awareness Related to Ablation Procedures
5.2.4 Challenges
5.2.4.1 Product Recalls
5.2.4.2 Therapeutic Challenges
6 Industry Trends
6.1 Key Industry Trends: Ablation Market
6.1.1 Industry Consolidation
6.1.2 Increasing Focus of Global Players Towards Developing Nations
6.1.3 Increasing Funding for Ablation Product Development and Commercialization
6.1.4 Notable Developments in Microwave Ablation Segment
6.1.5 High Focus of Market Players Towards Development of Advanced Radiofrequency Ablation Devices
6.2 Reimbursement Scenario (Qualitative Insights)
6.3 Supply Chain Analysis
6.4 Porter’s Five Forces Analysis
6.4.1 Threat From New Entrants
6.4.2 Threat of Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry
7 Global Ablation Technology Market, By Type
7.1 Introduction
7.2 Radiofrequency Ablation
7.3 Laser/Light Ablation
7.4 Ultrasound Ablation
7.5 Electrical Ablation
7.6 Cryoablation
7.7 Microwave Ablation
7.8 Hydrothermal Ablation
8 Global Ablation Technology Market, By Product
8.1 Introduction
8.2 Radiofrequency Ablators
8.2.1 Temperature-Controlled Radiofrequency Ablators
8.2.2 Fluid-Cooled Radiofrequency Ablators
8.2.3 Robotic Catheter Manipulation Systems
8.3 Laser/Light Ablators
8.3.1 Excimer Laser Ablators
8.3.2 Cold Laser Ablators
8.4 Ultrasound Ablators
8.4.1 Ultrasonic Surgical Ablation Systems
8.4.2 High-Intensity Focused Ultrasound (HIFU) Ablators
8.4.3 Extracorporeal Shockwave Lithotripsy (ESWL) Systems
8.4.4 Magnetic Resonance-Guided Focused Ultrasound (MRGFUS) Ablators
8.5 Electrical Ablators
8.5.1 Argon Plasma/Beam Coagulators
8.5.2 Irreversible Electroporation Ablators
8.6 Cryoablation Devices
8.6.1 Tissue Contact Probes
8.6.2 Tissue Spray Probes
8.6.3 Epidermal and Subcutaneous Cryoablation Devices
8.7 Microwave Ablators
8.7.1 Microwave Thermotherapy Devices
8.8 Hydrothermal Ablators
8.8.1 Endometrial Hydrothermal Balloon Ablation Devices
9 Global Ablation Technology Market, By Application
9.1 Introduction
9.2 Cardiovascular Disease Treatment
9.3 Cancer Treatment
9.3.1 Liver Cancer
9.3.2 Kidney Cancer
9.3.3 Prostate Cancer
9.3.4 Lung Cancer
9.3.5 Bone Metastasis
9.3.6 Breast Cancer
9.4 Ophthalmologic Treatment
9.5 Pain Management
9.6 Gynecological Treatment
9.7 Urological Treatment
9.8 Orthopedic Treatment
9.9 Cosmetic/ Aesthetic Surgery
9.10 Other Treatments
10 Global Ablation Technology Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.1.1 Significant Volume of Ablation Procedures in the Country
10.2.1.2 Remarkable Adoption of Advanced Ablation Technology as Compared to Conventional Technology
10.2.1.3 Availability of Funding for Development of Novel Ablation Devices
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Rising Focus of Market Players
10.3.1.2 Large Number of Ongoing Clinical Trials
10.3.1.3 Favorable Healthcare Reimbursement Scenario
10.3.1.4 Growing Incidence of Cancer and Cardiovascular Diseases
10.3.2 France
10.3.2.1 Availability of Funding for Development of Novel Ablation Devices in the Country
10.3.2.2 Availability of Training Programs and Reimbursement for Certain Products in France
10.3.3 U.K.
10.3.3.1 Large Patient Population Base
10.3.3.2 Availability of Research Funding
10.3.3.3 Expanding Presence of Market Players
10.3.3.4 Government Recommendations Encouraging Adoption of Ablation Technology
10.3.4 Rest of Europe
10.3.4.1 Rapidly Increasing Aging Population in the Region
10.3.4.2 Increasing Market Penetration of Leading Ablation Manufacturers in the Region
10.3.4.3 Prominent Adoption of Ablation in Italy
10.4 Asia-Pacific
10.4.1 Increasing Government Initiatives in the Region
10.4.1.1 Awareness Programs and Conferences in APAC
10.4.1.2 Rising Focus of Market Players
10.4.2 Japan
10.4.2.1 Well-Developed Healthcare System
10.4.2.2 Rising Baby Boomer Population Coupled With Cancer Incidence in the Country
10.4.2.3 Rising Government Focus Towards the Development of the Medical Device Industry
10.4.3 China
10.4.3.1 High Incidence of Target Diseases and Rapidly Aging Population
10.4.4 India
10.4.4.1 Remarkable Patient Base in the Country
10.4.4.2 Improving Healthcare Infrastructure in the Country
10.4.4.3 Rising Focus of Global Players
10.4.5 Rest of Asia-Pacific
10.5 Rest of the World
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 New Product Launches & Approvals
11.3.2 Mergers & Acquisitions
11.3.3 Geographical Expansions
11.3.4 Agreements and Joint Ventures
11.3.5 Other Developments
12 Company Profiles
12.1 Introduction
12.2 Medtronic PLC
12.3 Biosense Webster, Inc. (A Subsidiary of Johnson & Johnson Inc.)
12.4 St. Jude Medical, Inc.
12.5 Boston Scientific Corporation
12.6 Angiodynamics, Inc.
12.7 Atricure, Inc.
12.8 Conmed Corporation
12.9 Olympus Corporation
12.10 Smith & Nephew
12.11 Galil Medical Inc. (Acquired By BTG International Ltd.)
The Global Radiofrequency Ablation Devices Market has been segmented as below:
By Type Analysis
• Light/Laser Ablation
• Hydrothermal Ablation
• Radiofrequency Ablation
• Microwave Ablation
• Electrical Ablation
• Cryoablation
• Ultrasound Ablation
By Product Analysis
Disposable Equipment
o Radiofrequency ablation single use electrodes
o Radiofrequency ablation single use probes
o Radiofrequency ablation needles
o Radiofrequency ablation cannulas
Reusable Equipment
o Radiofrequency ablation electrodes
o Radiofrequency ablation probes
Capital Equipment
o Radiofrequency ablation generator
By Application Analysis
• Surgical oncology
• Cosmetology
• Hypertension
• Gynecology
• Pain management
• Cardiology and cardiac rhythm management
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
